Key Events This Week
1 June: Stock opens at Rs.6,044.90, closes at Rs.6,066.25 (+0.35%) amid Sensex decline
2 June: Downgrade to Sell rating announced; stock dips to Rs.6,027.50 (-0.64%)
3 June: Stock rebounds strongly to Rs.6,113.05 (+1.42%) despite Sensex fall
4 June: Continued gains to Rs.6,200.10 (+1.42%) with positive technical signals
5 June: Week closes at Rs.6,172.30 (-0.45%) on mixed momentum
Procter & Gamble Health Ltd Gains 1.64%: 2 Key Factors Driving the Week
2026-06-13 14:04:10
Key Events This Week
8 June: Technical momentum shifts to mildly bullish
9 June: MarketsMOJO upgrades rating to Hold on improved fundamentals
12 June: Stock closes at Rs.6,273.55, up 1.39% on the day

Procter & Gamble Health Ltd Upgraded to Hold on Technical and Financial Improvements
2026-06-09 08:31:06Procter & Gamble Health Ltd has seen its investment rating upgraded from Sell to Hold, reflecting improvements across technical indicators, financial performance, valuation metrics, and overall quality. This shift comes amid a backdrop of strong quarterly results, positive price momentum, and a more favourable outlook compared to the broader market.
Read full news article
Procter & Gamble Health Ltd Technical Momentum Shifts Amid Mixed Signals
2026-06-08 08:00:37Procter & Gamble Health Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend on weekly charts, despite mixed signals from key indicators such as MACD, RSI, and moving averages. This nuanced technical picture, combined with the company’s recent price action and relative performance against the Sensex, offers investors a complex but insightful view of its near-term prospects.
Read full news article
Procter & Gamble Health Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals
2026-06-02 08:34:51Procter & Gamble Health Ltd has seen its investment rating upgraded from Hold to Sell, reflecting a complex interplay of improved financial metrics and deteriorating technical indicators. The company’s robust quarterly performance contrasts with cautious market sentiment, prompting a nuanced reassessment across quality, valuation, financial trend, and technical parameters.
Read full news article
Procter & Gamble Health Ltd Faces Mixed Technical Signals Amid Mildly Bearish Momentum
2026-06-02 08:02:39Procter & Gamble Health Ltd (P&G Health) has experienced a subtle but notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish stance. Despite a modest day gain of 0.35% to close at ₹6,066.25, the stock’s technical indicators reveal a complex picture of mixed signals, suggesting cautious investor sentiment amid broader market volatility.
Read full news articleProcter & Gamble Health Ltd Gains 8.69%: 5 Key Factors Driving the Week’s Momentum
2026-05-30 17:20:39
Key Events This Week
25 May: Mojo grade upgraded to Hold on technical improvements
26 May: Mixed technical signals amid sideways momentum
27 May: New 52-week high at Rs.6,701.4 and intraday surge of 13.29%
29 May: Week closes at Rs.6,044.90, down 3.24% on the day
Are Procter & Gamble Health Ltd latest results good or bad?
2026-05-27 19:32:40Procter & Gamble Health Ltd's latest financial results for Q4 FY26 present a complex picture of operational performance. The company reported net sales of ₹370.45 crores, reflecting a year-on-year growth of 19.12% compared to ₹310.99 crores in Q4 FY25. However, there was a slight sequential decline of 0.91% from the previous quarter, indicating some volatility in revenue generation. In terms of profitability, the net profit reached ₹94.60 crores, which is a significant year-on-year increase of 54.62% from ₹61.18 crores in the same quarter last year. This also represents a sequential growth of 22.07%, showcasing strong operational efficiency. The operating margin for the quarter stood at an impressive 36.60%, marking a substantial improvement from 26.02% in Q4 FY25, driven by effective cost management and a favorable product mix. The company's return on equity (ROE) was reported at 47.36%, indicating exce...
Read full news articleAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
18-Jun-2026 | Source : BSEThe Company has informed the Stock Exchange regarding the Presentation of the Analyst/Institutional investor meet scheduled to be held today.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
18-Jun-2026 | Source : BSEThe Company has informed the Stock Exchange regarding the transcript and link to the recording of the analyst/institutional investors meeting held earlier today.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
04-Jun-2026 | Source : BSEWe wish to inform you that the management of the Company will be hosting a virtual connect with analysts/ institutional investors on June 18th at 2.30 pm IST. Institutional investors/Analysts interested in joining the connect are requested to complete the registration on link provided in the attached intimation by June 8 2026. The company will share meeting link and details to the participants who have registered separately.
Corporate Actions
No Upcoming Board Meetings
Procter & Gamble Health Ltd has declared 1100% dividend, ex-date: 12 Feb 26
No Splits history available
No Bonus history available
No Rights history available







